Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID al…
What to know about PODD
Insulet Corporation is a large Healthcare company with a mixed financial profile. It scores well on growth and sentiment, but size is worth keeping an eye on.
Should you consider PODD?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Insulet Corporation is a large-cap Healthcare company with a mixed overall financial profile — it ranks in the top quarter of its Healthcare peers (9 of 59).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
Valuation is in the middle of the pack — neither obviously cheap nor stretched.
-
Growth is a clear strength — revenue and earnings are expanding faster than most peers, signalling strong demand for the company's products or services.
-
This stock pays no dividend — your return depends entirely on the share price rising over time.
-
The stock is more volatile than most S&P 500 names — it can swing sharply in both directions. This suits investors comfortable with bigger short-term moves.
-
Analyst sentiment is broadly positive and short interest is low — professionals who cover this stock are mostly optimistic about its near-term prospects.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how PODD compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 34.06 | Average |
| Forward P/E | 18.04 | Average |
| PEG Ratio | 1.30 | Above avg |
| Price to Sales | 3.48 | Average |
| Price to Book | 7.75 | Below avg |
| EV/EBITDA | 17.88 | Average |
| Earnings Yield | 2.94% | Average |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 71.01% | Top 25% |
| Operating Margin | 16.03% | Average |
| Net Profit Margin | 10.44% | Average |
| Return on Equity | 23.00% | Above avg |
| Return on Invested Capital | 9.74% | Top 25% |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 33.90% | Top 25% |
| Revenue Growth (3Y CAGR) | 27.54% | Top 25% |
| EPS Growth (YoY) | 159.00% | Top 25% |
| Free Cash Flow Growth | 18.13% | Above avg |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 2.49 | Top 25% |
| Debt to Equity | 0.78 | Above avg |
| Interest Coverage | 6.72 | Average |
| Altman Z-Score | 5.47 | Above avg |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | — | N/A |
| Payout Ratio | 0.00% | Top 25% |
| Dividend Growth (5Y) | — | N/A |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 3.84% | Average |
| OCF to Sales | 21.35% | Average |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 1.13 | Average |
| Volatility (30-Day) | 48.11% | Below avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 6.90% | Below avg |
| Avg. Analyst Rating | 1.42 | Top 25% |
| Target Upside % | 66.32% | Top 25% |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 10.1B | Below avg |
How does PODD compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to PODD — based on their financial profile.